Pages
Categories
News
- Debt restructuring agreement of CHO Morcenx validated by the Mont de Marsan’s Commercial Court
- Strategic reorientation of the CHO Morcenx site
- Restructuring of CHO Morcenx’s debt allowing a massive deleveraging of the Group
- Anil Bhat appointed as Group’s Chief Commercial Officer
- 2020 Half-Year Results
- FY2019 Annual Results
- 2019 half-year results
- Europlasma presents its strategic orientation
- Strengthened Management team and new organisation finalized
- 2018 Annual Results of the Group
- Update on the Group’s activity
- Business continuity plans adopted by the Commercial Court
- First measures to enable setting up the continuation plan
- Observation period maintained
- Update on legal proceedings progress
- Update on legal proceedings progress
- Legal proceedings update
- Group’s update
- Invitation to General Meeting of Shareholders
- Update on funding prospects
- Participation in Pollutec exhibition
- Consolidated half-year Results as at 30/06/2018
- 1st “Assises Nationales de la pyrogazéification” on 26 & 27 Sept. 2018
- Update on the Group’s commercial activity
- Update on the Group’s activity
- 2017 Annual Results of Europlasma Group
- EIB and Europlasma announce the signature of a € 30 million financing contract for the innovative CHO Tiper project
- Europlasma announces a capital increase in its subsidiary CHO Power, valuing it at €101 million, and a simultaneous reorganisation of CHO Morcenx
- The European Investment Bank intends to support the CHO Tiper project by providing up to 30 million euro of debt financing
- Number of shares and voting rights (at 31/08/2017 – 11 Sep 2017)